|
US5505941A
(en)
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US7045313B1
(en)
|
1982-11-30 |
2006-05-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
MY109299A
(en)
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
JP3282188B2
(ja)
|
1991-06-27 |
2002-05-13 |
日本電気株式会社 |
半導体メモリ装置
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
AU691175B2
(en)
|
1993-03-31 |
1998-05-14 |
Nippon Zeon Co., Ltd. |
Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
DK0690732T3
(da)
|
1994-01-21 |
2003-05-19 |
Powderject Vaccines Inc |
Gasdrevet genindførselsinstrument
|
|
GB9502879D0
(en)
|
1995-02-14 |
1995-04-05 |
Oxford Biosciences Ltd |
Particle delivery
|
|
US6265387B1
(en)
|
1995-10-11 |
2001-07-24 |
Mirus, Inc. |
Process of delivering naked DNA into a hepatocyte via bile duct
|
|
US6458560B1
(en)
|
1996-04-05 |
2002-10-01 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
US6451592B1
(en)
|
1996-04-05 |
2002-09-17 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
IL127692A0
(en)
|
1996-07-01 |
1999-10-28 |
Rhone Poulenc Rorer Sa |
Method for producing recombinant adenovirus
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
NZ505325A
(en)
|
1997-12-23 |
2003-07-25 |
Crucell Holland B |
Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells
|
|
US6972013B1
(en)
|
1998-07-13 |
2005-12-06 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
|
US7922709B2
(en)
|
1998-07-13 |
2011-04-12 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
|
US7608273B2
(en)
|
1998-08-12 |
2009-10-27 |
University Of Western Ontario |
Recombinant lentivirus encoding modified GP 120 signal sequences
|
|
AT408615B
(de)
|
1998-09-15 |
2002-01-25 |
Immuno Ag |
Neue influenzavirus-impfstoffzusammensetzung
|
|
JP4693244B2
(ja)
|
1999-03-18 |
2011-06-01 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
|
|
ATE528406T1
(de)
|
1999-04-29 |
2011-10-15 |
Gbp Ip Llc |
Verfahren und mittel zur herstellung von sicheren,rekombinanten lentivirusvektoren mit hohem titer
|
|
GB9923176D0
(en)
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
|
AU2001257611A1
(en)
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
ATE315660T1
(de)
|
2002-05-16 |
2006-02-15 |
Bavarian Nordic As |
Intergene regionen als insertionsstellen im genom von modifiziertem vaccinia virus ankara (mva)
|
|
AU2003263653A1
(en)
|
2002-09-27 |
2004-04-19 |
Daewoong Co., Ltd. |
A vaccine enhancing the protective immunity to hepatitis c virus using plasmid dna and recombinant adenovirus
|
|
US8287879B2
(en)
*
|
2003-10-16 |
2012-10-16 |
The Regents Of The University Of California |
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
|
|
US20080131940A1
(en)
|
2004-06-25 |
2008-06-05 |
Robert Chiu |
Target Cell-Specific Short Interfering Rna and Methods of Use Thereof
|
|
WO2006135436A2
(en)
|
2004-10-22 |
2006-12-21 |
University Of Florida Research Foundation, Inc. |
Inhibition of gene expression and therapeutic uses thereof
|
|
US7541046B1
(en)
|
2005-01-04 |
2009-06-02 |
Gp Medical, Inc. |
Nanoparticles for protein drug delivery
|
|
US7611690B2
(en)
|
2005-01-04 |
2009-11-03 |
Gp Medical, Inc. |
Nanoparticles for protein drug delivery
|
|
US8048404B1
(en)
|
2005-01-04 |
2011-11-01 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles for protein drug delivery
|
|
CA2605924A1
(en)
|
2005-04-24 |
2006-11-02 |
Acambis Inc. |
Recombinant flavivirus vaccines
|
|
AR054822A1
(es)
|
2005-07-07 |
2007-07-18 |
Sanofi Pasteur |
Emulsion inmuno adyuvante
|
|
JP2009525267A
(ja)
*
|
2006-01-11 |
2009-07-09 |
アエロヴァンス インコーポレイティッド |
ヒトおよび非ヒト霊長類において喘息を処置するための方法および組成物
|
|
AR066240A1
(es)
*
|
2007-04-23 |
2009-08-05 |
Wyeth Corp |
Metodos y composiciones para tratar y monitorear el tratamiento de trastornos asociados con il-13
|
|
US20120088814A1
(en)
*
|
2009-03-31 |
2012-04-12 |
Isis Pharmaceuticals, Inc. |
Methods of modulating an immune response to a viral infection
|
|
WO2011003138A1
(en)
*
|
2009-07-06 |
2011-01-13 |
The Australian National University |
Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor
|